Health Trials

About this trial

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Eligibility criteria

Qualifiers

The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)

The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.

The participant is ≥ 18 years of age.

The participant has signed an approved consent for this study (living patients only)

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
The University of Kansas Medical Center66160, Kansas CityKansas, United States

Sponsors and collaborators

University of Kansas Medical Center

Lead sponsor

Source ClinicalTrials.gov